Jump to content
World's Largest Herpes Support Group
Sign in to follow this  
Jingvi

Nanoviricides

Recommended Posts

Jingvi

Found this over at Hwerks.com, seems interesting (and fairly recent too):

http://www.2theadvocate.com/wbrz/videos/52955807.html

http://www.drugs.com/clinical_trials/nanoviricides-inc-herpes-study-results-discussed-cbs-news-report-7902.html

WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug 12, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.

“Over 90% of the people are infected with Herpes, whether they know it or not,” said Dr. Kousoulas, adding “it can manifest as cold sores or genital herpes. [These manifestations] can be very painful, especially for women.” He also commented that “Unlike true love, herpes is forever,” referring to the fact that the herpes virus goes dormant in the body between recurrent manifestations, and that there is at present no cure for herpes.

“A nanoviricide drug could be an important breakthrough,” he said, explaining, “the duration of a cold sore could be reduced drastically, from a month to just a few days [by applying a nanoviricide skin cream],” based on studies conducted in the laboratories at the Louisiana State University's (LSU) Division of Biotechnology and Molecular Medicine (BIOMMED). In cell culture testing, his laboratory found that certain nanoviricides eliminated 99.99% of the virus from infected cells.

Seems a bit too optimistic for my tastes, but then the video article went on to explain how they might try to figure out a way to reduce or even eliminate transmission rates with nanoviricides within the next year, and they've already received new grants in research money for testing. So we'll see how it plays out, here's hoping.

Share this post


Link to post
Share on other sites
Guest Seatortuga

Yay! I can't wait for something better in the near future!

Share this post


Link to post
Share on other sites
HerpSgBoy

This sound very promising. So glad there is still someone out there will research on HSV.

Don't know will singapore get cure, if there really is cure out there =(

Share this post


Link to post
Share on other sites
MinerT

I dont know about you herpsgboy but if a certin country has the cure, im flying there on the next plane available!!!

Share this post


Link to post
Share on other sites
dommyjack

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that it is developing FluCide(™), its flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has been shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1.

The Company has previously announced excellent results in both animal studies and cell culture studies against widely different influenza subtypes and strains. If these results are confirmed in further animal and human studies, then FluCide would likely be considered the best ever drug effective against all influenzas. The Company is communicating its capabilities to various agencies involved in the current epidemic response.

=====================

Offset Mortgages

How to find a credit card even with bad credit

Share this post


Link to post
Share on other sites
death2herpes

this is potentially only (possibly better) treatment, not a cure.

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

Advertisement

Try a Lysine supplement for cold sores

×

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.